Literature DB >> 23744147

Tracking tumor resistance using 'liquid biopsies'.

Klaus Pantel1, Luis A Diaz, Kornelia Polyak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23744147     DOI： 10.1038/nm.3233

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

1.  Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

Authors:  Tim Forshew; Muhammed Murtaza; Christine Parkinson; Davina Gale; Dana W Y Tsui; Fiona Kaper; Sarah-Jane Dawson; Anna M Piskorz; Mercedes Jimenez-Linan; David Bentley; James Hadfield; Andrew P May; Carlos Caldas; James D Brenton; Nitzan Rosenfeld
Journal:  Sci Transl Med       Date:  2012-05-30       Impact factor: 17.956

2.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

Review 3.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

4.  Detection and quantification of mutations in the plasma of patients with colorectal tumors.

Authors:  Frank Diehl; Meng Li; Devin Dressman; Yiping He; Dong Shen; Steve Szabo; Luis A Diaz; Steven N Goodman; Kerstin A David; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

5.  Development of personalized tumor biomarkers using massively parallel sequencing.

Authors:  Rebecca J Leary; Isaac Kinde; Frank Diehl; Kerstin Schmidt; Chris Clouser; Cisilya Duncan; Alena Antipova; Clarence Lee; Kevin McKernan; Francisco M De La Vega; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2010-02-24       Impact factor: 17.956

6.  Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.

Authors:  K C Allen Chan; Peiyong Jiang; Yama W L Zheng; Gary J W Liao; Hao Sun; John Wong; Shing Shun N Siu; Wing C Chan; Stephen L Chan; Anthony T C Chan; Paul B S Lai; Rossa W K Chiu; Y M D Lo
Journal:  Clin Chem       Date:  2012-10-11       Impact factor: 8.327

7.  Circulating mutant DNA to assess tumor dynamics.

Authors:  Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Nat Med       Date:  2007-07-31       Impact factor: 53.440

8.  Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing.

Authors:  Rebecca J Leary; Mark Sausen; Isaac Kinde; Nickolas Papadopoulos; John D Carpten; David Craig; Joyce O'Shaughnessy; Kenneth W Kinzler; Giovanni Parmigiani; Bert Vogelstein; Luis A Diaz; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2012-11-28       Impact factor: 17.956

9.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

10.  Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

Authors:  Ellen Heitzer; Martina Auer; Christin Gasch; Martin Pichler; Peter Ulz; Eva Maria Hoffmann; Sigurd Lax; Julie Waldispuehl-Geigl; Oliver Mauermann; Carolin Lackner; Gerald Höfler; Florian Eisner; Heinz Sill; Hellmut Samonigg; Klaus Pantel; Sabine Riethdorf; Thomas Bauernhofer; Jochen B Geigl; Michael R Speicher
Journal:  Cancer Res       Date:  2013-03-07       Impact factor: 12.701
View more
  15 in total

1.  Liquid biopsy: Potential and challenges.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Mol Oncol       Date:  2016-02-01       Impact factor: 6.603

Review 2.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Tumour heterogeneity: principles and practical consequences.

Authors:  Giorgio Stanta; Stephan Wenzel Jahn; Serena Bonin; Gerald Hoefler
Journal:  Virchows Arch       Date:  2016-07-13       Impact factor: 4.064

Review 4.  Pathologists and liquid biopsies: to be or not to be?

Authors:  Paul Hofman; Helmut H Popper
Journal:  Virchows Arch       Date:  2016-08-23       Impact factor: 4.064

Review 5.  Toward platelet transcriptomics in cancer diagnosis, prognosis and therapy.

Authors:  Anandi Krishnan; Sally Thomas
Journal:  Br J Cancer       Date:  2021-11-22       Impact factor: 9.075

Review 6.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

Review 7.  Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.

Authors:  Melody J Xu; Jay F Dorsey; Ravi Amaravadi; Giorgos Karakousis; Charles B Simone; Xiaowei Xu; Wei Xu; Erica L Carpenter; Lynn Schuchter; Gary D Kao
Journal:  Oncologist       Date:  2015-11-27

Review 8.  Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.

Authors:  Giulia Siravegna; Alberto Bardelli
Journal:  Mol Oncol       Date:  2015-12-17       Impact factor: 6.603

9.  Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.

Authors:  Ikram Ullah; Govindasamy-Muralidharan Karthik; Amjad Alkodsi; Una Kjällquist; Gustav Stålhammar; John Lövrot; Nelson-Fuentes Martinez; Jens Lagergren; Sampsa Hautaniemi; Johan Hartman; Jonas Bergh
Journal:  J Clin Invest       Date:  2018-02-26       Impact factor: 14.808

Review 10.  Translational implications of tumor heterogeneity.

Authors:  Mariam Jamal-Hanjani; Sergio A Quezada; James Larkin; Charles Swanton
Journal:  Clin Cancer Res       Date:  2015-03-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.